422 related articles for article (PubMed ID: 16197295)
1. Hyperhomocysteinemia and response of methionine cycle intermediates to vitamin treatment in renal patients.
Herrmann W; Obeid R
Clin Chem Lab Med; 2005; 43(10):1039-47. PubMed ID: 16197295
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine, cystathionine, methylmalonic acid and B-vitamins in patients with renal disease.
Herrmann W; Schorr H; Geisel J; Riegel W
Clin Chem Lab Med; 2001 Aug; 39(8):739-46. PubMed ID: 11592444
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
[TBL] [Abstract][Full Text] [Related]
4. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
[TBL] [Abstract][Full Text] [Related]
5. Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes.
Herrmann W; Schorr H; Obeid R; Makowski J; Fowler B; Kuhlmann MK
Clin Chem; 2005 May; 51(5):891-7. PubMed ID: 15774574
[TBL] [Abstract][Full Text] [Related]
6. Role of homocysteine, cystathionine and methylmalonic acid measurement for diagnosis of vitamin deficiency in high-aged subjects.
Herrmann W; Schorr H; Bodis M; Knapp JP; Müller A; Stein G; Geisel J
Eur J Clin Invest; 2000 Dec; 30(12):1083-9. PubMed ID: 11122323
[TBL] [Abstract][Full Text] [Related]
7. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine and Hyperhomocysteinaemia.
Zaric BL; Obradovic M; Bajic V; Haidara MA; Jovanovic M; Isenovic ER
Curr Med Chem; 2019; 26(16):2948-2961. PubMed ID: 29532755
[TBL] [Abstract][Full Text] [Related]
9. Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease.
Stam F; van Guldener C; Ter Wee PM; Jakobs C; de Meer K; Stehouwer CD
Kidney Int; 2005 Jan; 67(1):259-64. PubMed ID: 15610249
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional status.
Herrmann W; Isber S; Obeid R; Herrmann M; Jouma M
Clin Chem Lab Med; 2005; 43(10):1139-46. PubMed ID: 16197311
[TBL] [Abstract][Full Text] [Related]
11. Association of B vitamins status and homocysteine levels in elderly Taiwanese.
Chen KJ; Pan WH; Yang FL; Wei IL; Shaw NS; Lin BF
Asia Pac J Clin Nutr; 2005; 14(3):250-5. PubMed ID: 16169836
[TBL] [Abstract][Full Text] [Related]
12. Alteration of homocysteine catabolism in pre-eclampsia, HELLP syndrome and placental insufficiency.
Herrmann W; Hübner U; Koch I; Obeid R; Retzke U; Geisel J
Clin Chem Lab Med; 2004; 42(10):1109-16. PubMed ID: 15552268
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced pertubation of the aminothiol redox-status in patients with epilepsy: improvement by B-vitamins.
Apeland T; Frøyland ES; Kristensen O; Strandjord RE; Mansoor MA
Epilepsy Res; 2008 Nov; 82(1):1-6. PubMed ID: 18644700
[TBL] [Abstract][Full Text] [Related]
14. Parenteral vitamin B12 therapy of hyperhomocysteinemia in end-stage renal disease.
Hoffer LJ; Elian KM
Clin Invest Med; 2004 Feb; 27(1):10-3. PubMed ID: 15061579
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
[TBL] [Abstract][Full Text] [Related]
16. Hydroxocobalamin reduces hyperhomocysteinemia in end-stage renal disease.
Elian KM; Hoffer LJ
Metabolism; 2002 Jul; 51(7):881-6. PubMed ID: 12077735
[TBL] [Abstract][Full Text] [Related]
17. Effect of multivitamins on plasma homocysteine in patients with the 5,10 methylenetetrahydrofolate reductase C677T homozygous state.
Dell'edera D; Tinelli A; Milazzo GN; Malvasi A; Domenico C; Pacella E; Pierluigi C; Giuseppe T; Marcello G; Francesco L; Epifania AA
Mol Med Rep; 2013 Aug; 8(2):609-12. PubMed ID: 23818036
[TBL] [Abstract][Full Text] [Related]
18. Evidence of altered homocysteine metabolism in chronic renal failure.
Henning BF; Riezler R; Tepel M; Langer K; Raidt H; Graefe U; Zidek W
Nephron; 1999; 83(4):314-22. PubMed ID: 10575293
[TBL] [Abstract][Full Text] [Related]
19. Functional vitamin B12 deficiency and determination of holotranscobalamin in populations at risk.
Herrmann W; Obeid R; Schorr H; Geisel J
Clin Chem Lab Med; 2003 Nov; 41(11):1478-88. PubMed ID: 14656029
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine in ocular diseases.
Ajith TA; Ranimenon
Clin Chim Acta; 2015 Oct; 450():316-21. PubMed ID: 26343924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
